Dual index kit TT set a, 96 RXN, chromium single cell human TCR amplification kit, 16 rxns, chromium single cell human BCR amplification kit, 16 rxns, chromium next GEM single cell 5' kit V2, 4…
Ended Awarded
- Contract number
- 75N95025F00003
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,922
Award facts
- Contract value 100% obligated
- $23,921.70 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The contract is for the delivery of various 10X Genomics products and services, including single-cell and spatial analysis kits, instruments, and related support, to further NINDS research into neurological diseases and disorders. The total ceiling value of the contract is $23,921.70, with three firm fixed price delivery orders totaling $60,806.30 issued so far. The contract does not utilize any set-aside designations. 10X Genomics is the prime contractor, providing specialized reagents, kits, and platforms for advanced genomic analysis techniques such as single-cell RNA sequencing, single-cell ATAC sequencing, single-cell multi-omics, and spatial transcriptomics. This contract award is part of a larger $750,000 indefinite delivery contract between 10X Genomics and NINDS for optimization slides, reagents kits, and reagent delivery methods to support the institute's research efforts.
Description
Dual index kit TT set a, 96 RXN, chromium single cell human TCR amplification kit, 16 rxns, chromium single cell human BCR amplification kit, 16 rxns, chromium next GEM single cell 5' kit V2, 4 rxns, chromium next GEM chip k single cell kit, 48
Quick answers
Who was awarded contract 75N95025F00003?
75N95025F00003 was awarded to 10X Genomics, Inc. by National Institute on Drug Abuse (National Institutes of Health) on December 31, 2024.
How much is contract 75N95025F00003 worth?
The government has obligated $23,922 on 75N95025F00003.
Which agency awarded contract 75N95025F00003?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025F00003, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95025F00003 an order under another contract?
Yes. 75N95025F00003 is a delivery order under 75N95023D00018, an indefinite delivery contract.
Was contract 75N95025F00003 competed?
The extent of competition for 75N95025F00003 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award